Clinical Trials Logo
  1. Home
  2. Eyelash Hypotrichosis
  3. NCT01064882

Safety and Efficacy of Bimatoprost Ophthalmic Solution in Increasing Eyelash Prominence

Eyelash Hypotrichosis Clinical Trial

Clinical Trial Summary

This study will evaluate the safety and efficacy of bimatoprost ophthalmic solution 0.005% or 0.015% compared with bimatoprost ophthalmic solution 0.03% once-daily application to the upper eyelid margins in increasing eyelash prominence

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01064882
Study type Interventional
Source Allergan
Contact
Status Completed
Phase Phase 2
Start date March 2010
Completion date July 2010
View Details
See also
  Status Clinical Trial Phase
Completed NCT01229423 - Safety and Efficacy of LATISSE® in the Augmentation of Eyelashes of Korean Subjects Phase 4
Completed NCT01623479 - An Observational Study of Patients Treated With Bimatoprost 0.03% (Latisse®) for Hypotrichosis of the Eyelashes
Completed NCT01023841 - Safety and Efficacy of Bimatoprost Solution in Treating Eyelash Loss or Hypotrichosis in Children Phase 4
Completed NCT01391273 - Safety and Efficacy Study of Bimatoprost in Japanese Patients With Eyelash Hypotrichosis Phase 3
Completed NCT01391286 - Safety and Efficacy Study of Bimatoprost in Japanese Patients With Chemotherapy-Induced Eyelash Hypotrichosis Phase 3
Completed NCT02505776 - Safety and Patient Satisfaction With GLASH VISTA™ (Bimatoprost 0.03%) in the Treatment of Eyelash Hypotrichosis in Japan